awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36929734-2E78716F-EC1E-4F95-A445-2C0BDB41DCFD
Q36929734-2E78716F-EC1E-4F95-A445-2C0BDB41DCFD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36929734-2E78716F-EC1E-4F95-A445-2C0BDB41DCFD
Molecularly targeted approaches herald a new era of non-small-cell lung cancer treatment.
P2860
Q36929734-2E78716F-EC1E-4F95-A445-2C0BDB41DCFD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36929734-2E78716F-EC1E-4F95-A445-2C0BDB41DCFD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ac0f2af6712e2590d0367b6c1a8c2154c9d37023
P2860
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)